Clinical trial
GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)
NCT02528357
Study timeline
Study start (actual)2015-09-11Date precision: day
Registry last updated2021-05-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Neoplasmsunresolved
Interventions
GSK3174998DRUG
PembrolizumabDRUG · verified · RxNorm: pembrolizumab
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Merck Sharp & Dohme LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02528357 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.